Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Motor Activity 2Stomach Neoplasms 1Lung Neoplasms 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease 1Colorectal Neoplasms 1

Interventions

Fluorouracil 13pembrolizumab 12Paclitaxel 12Oxaliplatin 12Leucovorin 9Carboplatin 9Capecitabine 8Trastuzumab 7Nivolumab 7Cisplatin 7Radiotherapy 6Radiation 6Taxes 5Esophagectomy 5Drug Therapy 5Surgical Procedures, Operative 4Specimen Handling 4Irinotecan 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Radiotherapy, Intensity-Modulated 3Proton Therapy 3Immunotherapy 3zanidatamab 2ulixertinib 2trastuzumab biosimilar HLX02 2relatlimab 2durvalumab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × High-Intensity Interval Training × 90 days × Clear all
NCT07561840 2026-05-19

Exercise Training After Upper Gastrointestinal Cancer Surgery

Kansai Medical University

Phase NA Recruiting
171 enrolled
Gastrointestinal

Disease, Esophageal Neoplasms, Gastrointestinal Neoplasms, Motor Activity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡